Alphabet: Wells Fargo cuts target price to $371 from $417
Wells Fargo cut its target price for Alphabet to $371 from $417.
Related News
Moleculin completes dosing in Part A of pivotal Annamycin trial for AML
MBRX•
Organon declares quarterly dividend of $0.02 per share
OGN•
Aurinia Pharmaceuticals reports financial results for the three and nine months ended September 30, 2026
AUPH•
Central Puerto buys back shares worth AR$ 198 million
CEPU•
LKQ Corp: Raymond James cuts target price to $25 from $30
LKQ•